Metatron Health

Botanical species · safety record

Fraxinus ornus

The EFSA Compendium of Botanicals holds 4 constituent measurements for Fraxinus ornus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Fraxinus ornus L.

4Constituent measurements
0Safety records
4Cited sources
10Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 10 licensed products naming Fraxinus ornus as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Bark
  • Juice
  • Rhizome resin
  • Sap
  • Sève

What the records describe

Constituents measured

  • Coumarins2
  • Coumarin glycosides1
  • Lignans1

Plant parts

  • Bark2
  • Leaves2

Preparations

  • Solvent extraction4

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Coumarin glycosidesLeavesSolvent extraction—LC-MSResolve DOI
CoumarinsLeavesSolvent extraction—Nuclear Magnetic Resonance (NMR)Resolve DOI
LignansBarkSolvent extraction—Nuclear Magnetic Resonance (NMR)Resolve DOI
CoumarinsBarkSolvent extraction—Colorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Fini, Alessio., Guidi, Lucia., Ferrini, Francesco., Brunetti, Cecilia., Di Ferdinando, Martina., Biricolti, Stefano., Pollastri, Susanna., Calamai, Luca., Tattini, Massimiliano. Drought stress has contrasting effects on antioxidant enzymes activity and phenylpropanoid biosynthesis in Fraxinus ornus leaves: An excess light stress affair? . Journal of plant physiology, 2012, vol. 169, no. 10, p. 929-939. DOI
  2. Iossifova, T., Vogler, B., Kostova, I. Secoiridoid glucosides from Fraxinus ornus bark. Phytochemistry, 1998, vol. 49, no. 5, p. 1329-1332. DOI
  3. Iossifova, T., Kostova, I., Evstatieva, LN. Secoiridoids and hydroxycoumarins in Bulgarian Fraxinus species. Biochemical systematics and ecology, 1997, vol. 25, no. 3, p. 271-274. DOI
  4. Kostova, I. Hydroxycoumarins from Fraxinus ornus bark. Planta Medica, 1992.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature

Europe PMC

Every record indexed for this species, resolvable and re-runnable.

All species

Substance index

Search and browse every species this world holds under source and hash.

Before anything else

Safety Centre

Interactions, contraindications and the escalation boundary this world does not cross.

In its own terms

Traditions

How the living traditions approach preparation, use and context.